
Irish foreign investment chief hopes fall-out from Trump pharma tariffs limited
DUBLIN (Reuters) - Ireland's foreign direct investment agency is hopeful that the impact of threaten...
19th February, 2025

DUBLIN (Reuters) - Ireland's foreign direct investment agency is hopeful that the impact of threaten...
19th February, 2025

By Andrew Silver SHANGHAI (Reuters) – As Novo Nordisk and Eli Lilly expand sales of their popular di...
20th December, 2024

MADRID (Reuters) -Canadian fund Brookfield is planning to drop its plan to take over Spain’s Grifols...
27th November, 2024

(Reuters) – The main UK stock indexes were subdued on Friday, with losses in AstraZeneca and GSK wei...
15th November, 2024

Analysis-Europe faces long wait for weight-loss drugs as governments eye costs By Ludwig Burger and...
10th July, 2023

Spain’s Grifols names current chairman as CEO, ending family leadership By Joan Faus BARCELONA (Reut...
8th May, 2023

By Michael Erman and Patrick Wingrove NEW YORK (Reuters) – Pharmaceutical companies that made billio...
6th February, 2023

By Natalie Grover and Maggie Fick LONDON (Reuters) -The European Union’s drug regulator needs to do...
24th January, 2023

By Natalie Grover (Reuters) -AstraZeneca raised its full-year earnings outlook on Thursday after str...
10th November, 2022

By Natalie Grover (Reuters) -GSK beat third-quarter earnings forecasts on Wednesday and raised its 2...
2nd November, 2022

By Natalie Grover LONDON (Reuters) – Surging energy costs in Europe risk accelerating an exodus of c...
27th October, 2022

By Ludwig Burger FRANKFURT (Reuters) -Europe’s drugmakers have warned they may stop making some chea...
28th September, 2022